Drug Database
IN

influenza vaccine (GC Flu quadrivalent / GCFlu quadrivalent / GC3110A)

✓ Approved

Medigen Vaccines Biologics · Vaccine · Vaccine

What is influenza vaccine?

influenza vaccine is a vaccine developed by Medigen Vaccines Biologics. It is approved for therapeutic indications via injectable (others) or intramuscular (im) injection.

Drug Profile

Brand NamesGC Flu quadrivalent, GCFlu quadrivalent, GC3110A
CompanyMedigen Vaccines Biologics
Drug ClassVaccine, Large Molecules
RouteInjectable (Others), Intramuscular (IM) Injection
StatusApproved

Related Research Articles

PubMedFrontiers in immunology2026-10-22

A subunit vaccine protects A129 mice from death and joint swelling against lethal Chikungunya virus challenge.

Li Jiangfan J, Fang Ting T, Song Liyuan L, Qiang Li L et al.

Chikungunya virus (CHIKV) is primarily transmitted to humans through bites of infected Aedes mosquitoes, causing febrile illness as well as acute or chronic arthritis. With increasing reports in previously non-endemic regions, it poses an emerging threat to public health and a growing risk to travelers. Despite the recent approval of live-attenuated and virus-like particle-based vaccines, a safe, efficacious, and cost-effective vaccine remains urgently needed. The envelope glycoproteins E1 and E2, which play crucial roles in viral attachment and entry, are the major immunodominant structural proteins and can effectively elicit protective antibodies. We engineered mammalian cells to produce the ectodomains of the E1 and E2 glycoproteins and evaluated the protective efficacy of the resulting vaccine formulations in vivo. A two-dose vaccination regimen elicited high levels of antibodies and provided full protection against lethal challenge in A129 mice, preventing both death and joint swelling. These findings demonstrate the potential of this vaccine candidate against CHIKV and warrant its further development.

PubMedEmerging microbes & infections2026-10-22

Co-circulation of H5N1 and H5N6 High Pathogenicity Avian Influenza Viruses in Migratory Birds at a Coastal Wintering Site in China.

Hu Xinyu X, Xiang Haiyang H, Wang Wenhao W, Kong Yunyi Y et al.

Since 2020, H5Nx high Pathogenicity avian influenza viruses (HPAIVs) belonging to hemagglutinin (HA) clade 2.3.4.4b have undergone widespread dispersal in wild birds, posing substantial threats to global poultry populations and mammals worldwide. In this study, we report the co-circulation of clade 2.3.4.4b H5N1 and H5N6 HPAIVs associated with mortality events in Anseriformes and Charadriiformes at a coastal wintering site in Fujian Province, China. H5N1 and H5N6 viruses were identified in 4 species of waterfowl (Bean Goose, Eastern Spot-billed Duck, Eurasian Wigeon, and Eurasian Curlew). Phylogenetic analysis indicated that these H5N1 and H5N6 isolates were clade 2.3.4.4b strains circulating within Eurasia and lacked known mammalian adaptation markers in key proteins. The infected birds exhibited severe systemic multi-organ pathology, with the most pronounced damage observed in the lungs. H5N6 and H5N1 viruses caused lethal injury in BALB/c mice, with H5N1 leading to systemic infection. Environmental sampling also revealed the presence of H5N1 HPAIVs alongside low-pathogenicity avian influenza viruses (LPAIVs) such as H3N1 and H6N1. Our findings highlight the complex and dynamic transmission patterns of H5 HPAIV in wild bird populations and the substantial threat they pose to mammals, underscoring the critical importance of sustained surveillance for high pathogenicity avian influenza in wild birds.

PubMedThe Journal of organic chemistry2026-10-22

A Green and Scalable Protocol for Oxidative Cyclization of N-Acylamidines with Oxone-Halide.

Chen Shiji S, Hu Shixiu S, You Shujun S, Li Yuxiao Y et al.

Oxidative cyclization of N-acylamidines is one of the most widely used approaches to yield 1,2,4-oxadiazoles, which are prevalent in many bioactive molecules and drugs. Herein, we report a scalable and green protocol using oxone and halide to achieve this transformation, affording the desired 1,2,4-oxadiazoles (32 examples, up to 93% yield) with readily removable inorganic salts as byproducts. This method offers distinct advantages over previous procedures, including operational simplicity, tolerance to air and moisture, ambient temperature, and no requirement for specialized equipment or expensive reagents. Notably, three oxadiazole-based agents were efficiently synthesized from the corresponding N-acylamidines via this protocol. Given its practical scalability and environmental friendliness, this approach is expected to find broad applications in organic synthesis and process chemistry.

PubMedThe Journal of the Association of Physicians of India2026-10-22

Feasibility of a Model-based HbA2 Prediction for Low-cost Screening of β-thalassemia Trait Using Blood-derived Indices: Opportunities and Challenges.

Peraka Ramadevi R, M Pradeep Kumar Reddy PKR, S Vanajakshi V, Avadhanam Sumedha S et al.

β-thalassemia trait (β-TT) is a common genetic condition with significant public health implications, particularly in regions with high prevalence. Diagnosis conventionally relies on HbA2 quantification using high-performance liquid chromatography or Hemoglobin electrophoresis, which are costly and inaccessible in resource-limited settings. Developing low-cost screening/triage tools is therefore essential. A retrospective single-center cross-sectional study was conducted at the Department of Pathology, Apollo Institute of Medical Sciences & Research, Hyderabad, between February 2023 and December 2025. Data from 129 patients with complete blood counts, iron profiles, and HbA2 measurements were analyzed. LASSO method was applied to identify salient predictors of HbA2 from demographic, hematological, and iron parameters. Two ordinary least squares regression models (OLS) were constructed: one excluding iron parameters (model 1) and another incorporating iron parameters (model 2). LASSO-then-OLS approach was used for both 5-fold cross-validation and final model development. ROC analysis was also done. Of the 129 patients, 15 (11.6%) had β-TT (HbA2 >3.5%). The 5-fold cross-validation found lower root mean squared error (RMSE) and superior variable selection stability with an iron parameter-inclusive model. Salient predictors in the final model were age, RBC count, MCV, and RDW-CV in model 1, while model 2 additionally included serum ferritin, transferrin saturation, and total iron binding capacity (TIBC). Age and RBC count were positively associated with HbA2, while MCV, RDW-CV, serum ferritin, and TIBC were negatively associated. Model 1 explained 40% of HbA2 variance, while model 2 explained 47% variance. Model imprecision was more pronounced for β-TT cases. ROC analysis showed an area under the curve (AUC) value of 0.868 (0.766-0.969) for model 1 and 0.904 (0.829-0.98) for model 2. Optimal cutoff (3.31% from model 1 and 3.26% from model 2) for β-TT detection was lower than the conventional threshold. Regression-based machine learning models have the potential to estimate HbA2 using routine blood indices, offering a cost-effective screening/triage before specialized assays. Such models are particularly valuable in populations with prevalent iron deficiency anemia (serum ferritin <12 ng/ml), where fixed HbA2 cutoffs are unreliable. Larger studies incorporating peripheral smear image analysis are needed to improve the predictive accuracy of models before they can be deployed clinically.

PubMedThe Plant journal : for cell and molecular biology2026-10-22

Red to green: catching gene silencing as it takes hold.

Wood Charlay C

PubMedEpidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil2026-10-22

[Strategies to address vaccine hesitancy in Brazil: evidence synthesis].

Marques Ana Paula da Costa APDC, Gubert Vanessa Terezinha VT, Dias Adriano da Costa ADC, Gasparoto Antonio Luiz Dal Bello ALDB et al.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about influenza vaccine